Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Xenobiotics | 1 | 2019 | 78 | 0.700 |
Why?
|
| Thiosemicarbazones | 1 | 2018 | 15 | 0.690 |
Why?
|
| Copper | 1 | 2018 | 380 | 0.540 |
Why?
|
| NADP | 1 | 2016 | 255 | 0.530 |
Why?
|
| Oximes | 1 | 2016 | 317 | 0.520 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 699 | 0.410 |
Why?
|
| Iron | 2 | 2017 | 1735 | 0.340 |
Why?
|
| Cell Death | 7 | 2017 | 1724 | 0.340 |
Why?
|
| Computational Biology | 1 | 2021 | 3571 | 0.330 |
Why?
|
| Liver | 2 | 2021 | 7594 | 0.300 |
Why?
|
| Sulfonamides | 1 | 2016 | 1922 | 0.300 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13626 | 0.280 |
Why?
|
| Glutathione Peroxidase | 2 | 2017 | 261 | 0.260 |
Why?
|
| Apoptosis | 5 | 2020 | 9971 | 0.250 |
Why?
|
| Kidney | 1 | 2019 | 6882 | 0.240 |
Why?
|
| Glioblastoma | 1 | 2018 | 3346 | 0.230 |
Why?
|
| Neoplasms | 5 | 2021 | 20528 | 0.230 |
Why?
|
| Cell Line, Tumor | 9 | 2021 | 16735 | 0.220 |
Why?
|
| Growth Differentiation Factor 15 | 2 | 2021 | 161 | 0.210 |
Why?
|
| Carbolines | 2 | 2014 | 256 | 0.210 |
Why?
|
| Protein Prenylation | 1 | 2020 | 79 | 0.200 |
Why?
|
| Colchicine | 1 | 2021 | 251 | 0.190 |
Why?
|
| Genes, Essential | 1 | 2021 | 185 | 0.190 |
Why?
|
| Small Molecule Libraries | 2 | 2018 | 725 | 0.180 |
Why?
|
| Lipid Peroxidation | 2 | 2017 | 312 | 0.180 |
Why?
|
| Myeloid Cells | 1 | 2021 | 780 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2016 | 752 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 3206 | 0.130 |
Why?
|
| Cyclohexylamines | 1 | 2014 | 21 | 0.130 |
Why?
|
| Coumarins | 1 | 2014 | 121 | 0.130 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 3574 | 0.130 |
Why?
|
| Phenylenediamines | 1 | 2014 | 90 | 0.120 |
Why?
|
| Membrane Lipids | 1 | 2014 | 253 | 0.120 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2014 | 184 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2020 | 1179 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 6482 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10615 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 795 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2279 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2099 | 0.100 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2009 | 51 | 0.090 |
Why?
|
| Signal Transduction | 5 | 2021 | 23729 | 0.090 |
Why?
|
| Genes, ras | 1 | 2012 | 706 | 0.090 |
Why?
|
| Gentamicins | 1 | 2009 | 260 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 380 | 0.090 |
Why?
|
| Benzamides | 1 | 2014 | 1390 | 0.090 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 292 | 0.080 |
Why?
|
| Internet | 1 | 2021 | 3079 | 0.080 |
Why?
|
| Cytokines | 2 | 2021 | 7189 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1990 | 0.080 |
Why?
|
| Huntington Disease | 1 | 2014 | 1183 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2011 | 989 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3129 | 0.070 |
Why?
|
| Software | 1 | 2021 | 4396 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 11201 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 933 | 0.070 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 601 | 0.060 |
Why?
|
| Th2 Cells | 1 | 2009 | 1053 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1634 | 0.060 |
Why?
|
| Piperazines | 1 | 2014 | 2524 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2014 | 2124 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 2137 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1842 | 0.050 |
Why?
|
| Humans | 14 | 2021 | 715818 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2021 | 133 | 0.050 |
Why?
|
| Triamterene | 1 | 2020 | 3 | 0.050 |
Why?
|
| Microtubules | 2 | 2021 | 1208 | 0.050 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2020 | 57 | 0.050 |
Why?
|
| Lovastatin | 1 | 2020 | 116 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3897 | 0.050 |
Why?
|
| Peritonitis | 1 | 2021 | 378 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 337 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4647 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2014 | 1951 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2699 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2017 | 64 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 190 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5947 | 0.040 |
Why?
|
| Mesoderm | 1 | 2017 | 723 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2021 | 1238 | 0.030 |
Why?
|
| Methotrexate | 1 | 2020 | 1725 | 0.030 |
Why?
|
| Antioxidants | 1 | 2021 | 1670 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 626 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 913 | 0.030 |
Why?
|
| Smoking | 1 | 2009 | 8980 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 714 | 0.030 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 69 | 0.030 |
Why?
|
| Cell Survival | 2 | 2012 | 6035 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 606 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 459 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 408 | 0.020 |
Why?
|
| Thioglycolates | 1 | 2009 | 39 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 293 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 2009 | 45 | 0.020 |
Why?
|
| Hair Removal | 1 | 2009 | 37 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2124 | 0.020 |
Why?
|
| Lysosomes | 1 | 2014 | 894 | 0.020 |
Why?
|
| Interleukin-5 | 1 | 2009 | 260 | 0.020 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2009 | 109 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 2009 | 181 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1703 | 0.020 |
Why?
|
| Lipids | 1 | 2020 | 3242 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2009 | 357 | 0.020 |
Why?
|
| Dystrophin | 1 | 2009 | 284 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 2299 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2017 | 2594 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22663 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 336 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2009 | 281 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 606 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2009 | 704 | 0.020 |
Why?
|
| Permeability | 1 | 2009 | 786 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6105 | 0.020 |
Why?
|
| Mice | 4 | 2021 | 80373 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 1941 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2014 | 931 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 868 | 0.020 |
Why?
|
| Thiophenes | 1 | 2011 | 600 | 0.020 |
Why?
|
| Cell Line | 2 | 2011 | 16575 | 0.020 |
Why?
|
| Drug Design | 1 | 2012 | 1099 | 0.020 |
Why?
|
| Epidermis | 1 | 2009 | 538 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 568 | 0.020 |
Why?
|
| Male | 4 | 2018 | 350352 | 0.020 |
Why?
|
| Oncogenes | 1 | 2011 | 1246 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3149 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1912 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2009 | 899 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1603 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 2399 | 0.020 |
Why?
|
| Animals | 5 | 2021 | 169404 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1255 | 0.020 |
Why?
|
| Proteomics | 1 | 2017 | 3248 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2009 | 1074 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 14161 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5198 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 2562 | 0.010 |
Why?
|
| DNA Damage | 1 | 2011 | 2434 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2011 | 4228 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 2946 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3484 | 0.010 |
Why?
|
| Melanoma | 1 | 2017 | 5250 | 0.010 |
Why?
|
| Female | 1 | 2018 | 377229 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 19537 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 2956 | 0.010 |
Why?
|
| Pneumonia | 1 | 2009 | 2099 | 0.010 |
Why?
|
| Models, Biological | 1 | 2014 | 9809 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7885 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9849 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8571 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 24852 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 10605 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4931 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 9739 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 29290 | 0.000 |
Why?
|
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_